Literature DB >> 26149584

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26149584     DOI： 10.1111/aos.12793

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  3 in total

1.  Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-18       Impact factor: 3.117

2.  Central retinal vein occlusion in a young adult Case report.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Rom J Ophthalmol       Date:  2016 Apr-Jun

Review 3.  Bevacizumab in the treatment of acute central/hemicentral retinal vein occlusions.

Authors:  Dan Călugăru; Mihai Călugăru; Ștefan Țălu
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.